A paradigm shift in cancer research based on integrative multi-omics approaches: glutaminase serves as a pioneering cuproptosis-related gene in pan-cancer.

Detalles Bibliográficos
Publicado en:BMC Women's Health Vol. 24; no. 1; pp. 1 - 32
Autores principales: Shi, Hai-hong, Mugaanyi, Joseph, Lu, Changjiang, Li, Yang, Huang, Jing, Dai, Lei
Formato: Journal Article
Publicado: BioMed Central 4/2/2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=176406022&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 176406022
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14726874
        1CIP
      jtl: BMC Women's Health
      issn: 14726874
      maglogo: N
    pubinfo:
      dt: 4/2/2024
      vid: 24
      iid: 1
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        176406022
        10.1186/s12905-024-03061-8
        176406022
      ppf: 1
      ppct: 31
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: A paradigm shift in cancer research based on integrative multi-omics approaches: glutaminase serves as a pioneering cuproptosis-related gene in pan-cancer.
      aug:
        au:
          Shi, Hai-hong
          Mugaanyi, Joseph
          Lu, Changjiang
          Li, Yang
          Huang, Jing
          Dai, Lei
        affil: Department of Hepato-Pancreato-Biliary Surgery, Ningbo Medical Center Li Huili Hospital, The Affiliated Hospital of Ningbo University, 315040, Ningbo, China
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N